Tom Schoenherr

Dec 14, 2017

Tom Schoenherr has been appointed as Ambry Genetics' chief commercial officer, following Ambry's acquisition by Konica Minolta in October. Previously, he led commercial strategy at Counsyl, and before that, he held similar roles at Quest, Siemens Healthcare, and Abbott Diagnostics.

Breaking News

Applied DNA Sciences Subsidiary Gets CLIA Certification From NY State Department of Health
Biocartis Receives €1.4M Grant to Develop New Technology for Molecular Surveillance
Berkeley Lights Q1 Revenues Grow 35 Percent
Bio Molecular Systems Gets CE-IVD Mark, Australian Approval for Portable PCR Cycler
Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test
NanoString Technologies Q1 Revenues Grow 19 Percent

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.